medigraphic.com
ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)

2006, Number S1

<< Back Next >>

Rev Mex Anest 2006; 29 (S1)

TIVA: Its role in modern anesthesia

Muñoz-Cuevas JH

Language: Spanish
References: 29
Page: 141-147
PDF size: 81.41 Kb.


Text Extraction

No abstract


REFERENCES

  1. Kanto J. Pharmacocinetic implications for the clinical use of propofol. Clin Pharmacokinet 1989;17(5):308-326.

  2. Kruger-Theimer E. Continous intravenous infusion and multicompartmenn accumulation. Eur J Pharmacol 1968;4:317-324.

  3. Schwilden H. A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Pharmacol 1981; 20:379-380.

  4. Smith C. The interaction of fentanil on the Cp 50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994;81(4):820-828.

  5. Schnider TW. The effect compartment in pharmacodynamic modeling. Anesthetic Pharmacology Review 1994;2:204-213.

  6. Schnider TW. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998;88(5):1170-1182.

  7. Schafer SL. Algorithm of rapidly achieve and maintain stable concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinetic Biopharma 1992; 20:147-169.

  8. Doze VA. Propofol-nitrous oxide versus thiopental-isofluoranenitrous oxide for general anesthesia. Anesthesiology 1988;69:6371-6380.

  9. Lee JA. history of Anaesthesia, Lee´s synopsis of Anaesthesia, II Edition. Edited by Atkinson RS, Rushman GA, Davis NJH. Oxford, Butterworth Heinemann, 1996: 875-915.

  10. Sepúlveda P. ¿Cómo construir una TIVA en forma manual? La Anestesia Intravenosa Bases Teóricas y Experiencias Clínicas. Primera Edición. Editor: Universidad del Desarrollo, Santiago de Chile, Enero 2004: 61-69.

  11. White P. Clinical uses of intravenous anesthetic an analgesic infusions. Anesth Analg 1989;68:161-171.

  12. Vuyk J. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol concentrations that assure adequate anaesthesia and a rapid return of consciousness. Anesthesiology 1997;87:1549-1562.

  13. Kezama T. Pharmacodymanic interaction between propofol and fentanilo with respect to the suppression of somatic or hemodynamic response to skin incision, peritoneum incision and abdominal wall retraction. Anesthesiology 1998;89:894-906.

  14. Gepts E. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995;83(6):1196-1204.

  15. Maitre PO. Population pharmacokinetics of alfentanil: the average dose-plasma concentrations relationship and interindividual variability in patients. Anesthesiology 1987;66(1):3-12.

  16. Minto CF. Pharmacokinetics and pharmocodynamic of remifentanil (II); model application. Anesthesiology 1997;86(1):24-33.

  17. Bovil JG. Adverse drugs interactions in anesthesia. J Clin Anesth 1997;9(6 Suppl):3-13S.

  18. Mertens MJ. Performance of computer-controlled infusion of remifentanil during propofol-remifentanil anesthesia. Br J Anaesth 2003;90(2):132-141.

  19. Egan TD. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamic in healthy adult male volunteers. Anesthesiology 1996;84(4):821-833.

  20. Vuyk J. Performance of computer-controlled infusion of propofol: an evaluation of five pharmacodynamic parameter sets. Anesth Analg 1995;81(6):1275-1282.

  21. Moerman N. Awareness and recall during general anesthesia. Anesthesiology 1993;79:454-464.

  22. Carrasco MS. Monitoring of autonomic nervous system response to gynecological procedures under TIVA. 10th. ISAP Annual Meeting Refresher Lectures. October 2001. 14.

  23. Rampill I. A primer for EEG signal processing in anesthesia. Anesthesiology 1998;89:980-1002.

  24. Glass PS Biespectral Analysis measures sedation and memory effects of propofol, midazolam, isofluorano and alfentanil in healthy volunteers. Anesthesiology 1997;86(4):836-847.

  25. Struys MM. Comparison of plasma compartment versus two methods for effect compartment-controlled target-controlled infusion for propofol. Anesthesiology 2000;92:399-406.

  26. Drover D. Patient State Index. Anesthesiology 2002;97(1):82-88.

  27. Struys MM. Comparison of closed-loop controlled administration using Biespectral index as the controlled variable versus “standard practice” controlled administration. Anesthesiology 2001;95(1):6-17.

  28. Bell SL. The auditory middle latency response. Evoked using maximum length sequences and chirps, as an indicator of adequacy of anesthesia. Anesth Analg 2006;102:495-498.

  29. Lichtenbelt BJ. Strategies to optimise propofol-opioid anaesthesia. Clin Pharmacokinet 2004;43(9):577-593.




2020     |     www.medigraphic.com